NFKB1 and breast carcinoma: These results indicate that Andro inactivates NF-κB signaling to inhibit the expression of miR-21-5p, and the inhibition of miR-21-5p stimulates PDCD4 expression to inhibit luminal-like breast cancer growth, metastasis, and invasion.